Cargando…
Head and neck cancer predictive risk estimator to determine control and therapeutic outcomes of radiotherapy (HNC-PREDICTOR): development, international multi-institutional validation, and web implementation of clinic-ready model-based risk stratification for head and neck cancer
BACKGROUND: Personalised radiotherapy can improve treatment outcomes of patients with head and neck cancer (HNC), where currently a ‘one-dose-fits-all’ approach is the standard. The aim was to establish individualised outcome prediction based on multi-institutional international ‘big-data’ to facili...
Autores principales: | van Dijk, Lisanne V., Mohamed, Abdallah SR., Ahmed, Sara, Nipu, Nafiul, Marai, G. Elisabeta, Wahid, Kareem, Sijtsema, Nanna M., Gunn, Brandon, Garden, Adam S., Moreno, Amy, Hope, Andrew J., Langendijk, Johannes A., Fuller, Clifton D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853413/ https://www.ncbi.nlm.nih.gov/pubmed/36442460 http://dx.doi.org/10.1016/j.ejca.2022.10.011 |
Ejemplares similares
-
Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria
por: Oga, Emmanuel A., et al.
Publicado: (2016) -
Salivary Cytokines in patients with Head and Neck Cancer (HNC) treated with Radiotherapy
por: Principe, Sara, et al.
Publicado: (2019) -
MR-Guided Adaptive Radiotherapy for OAR Sparing in Head and Neck Cancers
por: Mulder, Samuel L., et al.
Publicado: (2022) -
Young population awareness of head and neck cancer's (HNC) risk factors, symptoms and prognosis – a pilot survey
por: Krentowska, Anna, et al.
Publicado: (2015) -
BMSC–HNC Interaction: Exploring Effects on Bone Integrity and Head and Neck Cancer Progression
por: Eichberger, Jonas, et al.
Publicado: (2023)